Cargando…

The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment

BACKGROUND: Topotecan produces DNA damage that induces autophagy in cancer cells. In this study, sensitising topotecan to colon cancer cells with different P53 status via modulation of autophagy was examined. METHODOLOGY/PRINCIPAL FINDINGS: The DNA damage induced by topotecan treatment resulted in c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dan-Dan, Sun, Ting, Wu, Xiao-Qi, Chen, Shu-Peng, Deng, Rong, Jiang, Shan, Feng, Gong-Kan, Pan, Jing-Xuan, Zhang, Xiao-Shi, Zeng, Yi-Xin, Zhu, Xiao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443203/ https://www.ncbi.nlm.nih.gov/pubmed/23024792 http://dx.doi.org/10.1371/journal.pone.0045058

Ejemplares similares

Mutant p53 in colon cancer
por: Nakayama, Mizuho, et al.
Publicado: (2018)

JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy
por: Sui, Xinbing, et al.
Publicado: (2014)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin
por: Therachiyil, Lubna, et al.
Publicado: (2020)

Mutant p53 as a Regulator and Target of Autophagy
por: Shi, Yong, et al.
Publicado: (2021)

Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells
por: Wang, Yao, et al.
Publicado: (2011)

Retraction Note: JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy
por: Sui, Xinbing, et al.
Publicado: (2021)

p53’s Extended Reach: The Mutant p53 Secretome
por: Pavlakis, Evangelos, et al.
Publicado: (2020)

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
por: Bollu, Lakshmi Reddy, et al.
Publicado: (2020)

A Novel P53-Related Activity in a Colon Adenocarcinoma Cell Line With Mutant P53
por: Gartel, Andrei L., et al.
Publicado: (2001)

Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a “dominant-positive” mechanism
por: Walerych, Dawid, et al.
Publicado: (2018)

Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway
por: Xie, Haibiao, et al.
Publicado: (2021)

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
por: Bourdon, Jean-Christophe, et al.
Publicado: (2011)

Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
por: Lu, Phong, et al.
Publicado: (2019)

Editorial: Advances in wild type and mutant p53 research in cancer
por: Hernández-de la Cruz, Olga N., et al.
Publicado: (2022)

Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation
por: Kaypee, Stephanie, et al.
Publicado: (2018)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines
por: Poele, R H te, et al.
Publicado: (1999)

p53 tetramerization: at the center of the dominant-negative effect of mutant p53
por: Gencel-Augusto, Jovanka, et al.
Publicado: (2020)

Mutant p53 Cooperates with Knockdown of Endogenous Wild-Type p53 to Disrupt Tubulogenesis in Madin-Darby Canine Kidney Cells
por: Zhang, Yanhong, et al.
Publicado: (2013)

Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties
por: Nakayama, Mizuho, et al.
Publicado: (2020)

Functional Diversity of p53 in Human and Wild Animals
por: Li, Yi, et al.
Publicado: (2019)

Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
por: Zhang, Shengliang, et al.
Publicado: (2022)

NF-κB is involved in the regulation of autophagy in mutant p53 cells in response to ionizing radiation
por: Zhu, Ying, et al.
Publicado: (2021)

P53 Mutant p53(N236S) Regulates Cancer-Associated Fibroblasts Properties Through Stat3 Pathway
por: Liu, Qing, et al.
Publicado: (2020)

Big bones in p53 mutants
por: LeBrasseur, Nicole
Publicado: (2006)

Mutant p53 succumbs to starvation
por: Moon, Sung-Hwan, et al.
Publicado: (2013)

Chromatin dysregulation by mutant p53
por: Pfister, Neil T., et al.
Publicado: (2016)

Mutant p53 partners in crime
por: Kim, Michael P, et al.
Publicado: (2018)

Editor's Note on ‘Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53’
Publicado: (2023)

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
por: van Oosterwijk, J G, et al.
Publicado: (2013)

Asperolide A induces apoptosis and cell cycle arrest of human hepatoma cells with p53-Y220C mutant through p38 mediating phosphorylation of p53 (S33)
por: Lv, Cuiting, et al.
Publicado: (2023)

Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
por: de Bruijn, M T, et al.
Publicado: (2010)

Directing p53 to induce autophagy
por: Mayo, Lindsey D.
Publicado: (2012)

p53-induced autophagy and senescence
por: Sui, Xinbing, et al.
Publicado: (2015)

p53-Autophagy-Metastasis Link
por: Denisenko, Tatiana V., et al.
Publicado: (2018)

p53 Inhibition Protects against Neuronal Ischemia/Reperfusion Injury by the p53/PRAS40/mTOR Pathway
por: Zhao, Jianlan, et al.
Publicado: (2021)

Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Temperature sensitivity of human wild-type and mutant p53 proteins expressed in vivo.
por: Ponchel, F., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_ph1bj8fe9dg1jm24ungc0l977n